Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Carisbamate in essential tremor: brief report of a proof of concept study.

Elble RJ, Biondi DM, Ascher S, Wiegand F, Hulihan J.

Mov Disord. 2010 Apr 15;25(5):634-8. doi: 10.1002/mds.22872.

PMID:
20201005
2.

Topiramate in essential tremor: findings from double-blind, placebo-controlled, crossover trials.

Connor GS, Edwards K, Tarsy D.

Clin Neuropharmacol. 2008 Mar-Apr;31(2):97-103. doi: 10.1097/WNF.0b013e3180d09969.

PMID:
18382182
3.

Levetiracetam is not effective for essential tremor.

Elble RJ, Lyons KE, Pahwa R.

Clin Neuropharmacol. 2007 Nov-Dec;30(6):350-6.

PMID:
18090460
4.

A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.

Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL.

Mov Disord. 2007 Jan 15;22(2):279-82.

PMID:
17149715
5.

Efficacy and tolerability of pregabalin in essential tremor: a randomized, double-blind, placebo-controlled, crossover trial.

Ferrara JM, Kenney C, Davidson AL, Shinawi L, Kissel AM, Jankovic J.

J Neurol Sci. 2009 Oct 15;285(1-2):195-7. doi: 10.1016/j.jns.2009.06.044.

PMID:
19631949
6.

Evaluation of carisbamate, a novel antiepileptic drug, in photosensitive patients: an exploratory, placebo-controlled study.

Trenité DG, French JA, Hirsch E, Macher JP, Meyer BU, Grosse PA, Abou-Khalil BW, Rosenfeld WE, van Gerven J, Novak GP, Parmeggiani L, Schmidt B, Gibson D, Guerrini R.

Epilepsy Res. 2007 May;74(2-3):193-200.

PMID:
17448639
7.
8.

Mirtazapine in essential tremor: a double-blind, placebo-controlled pilot study.

Pahwa R, Lyons KE.

Mov Disord. 2003 May;18(5):584-7.

PMID:
12722174
9.

Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial.

Cady RK, Mathew N, Diener HC, Hu P, Haas M, Novak GP; Study Group..

Headache. 2009 Feb;49(2):216-26. doi: 10.1111/j.1526-4610.2008.01326.x.

PMID:
19222595
10.

Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures.

Faught E, Holmes GL, Rosenfeld WE, Novak G, Neto W, Greenspan A, Schmitt J, Yuen E, Reines S, Haas M.

Neurology. 2008 Nov 11;71(20):1586-93. doi: 10.1212/01.wnl.0000334751.89859.7f.

PMID:
19001248
11.

Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.

Smith T, DiBernardo A, Shi Y, Todd MJ, Brashear HR, Ford LM.

Pain Pract. 2014 Apr;14(4):332-42. doi: 10.1111/papr.12080.

PMID:
23692321
12.

Zonisamide for essential tremor: an evaluator-blinded study.

Handforth A, Martin FC, Kang GA, Vanek Z.

Mov Disord. 2009 Feb 15;24(3):437-40. doi: 10.1002/mds.22418.

PMID:
19117357
13.
14.

A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor.

Zesiewicz TA, Ward CL, Hauser RA, Salemi JL, Siraj S, Wilson MC, Sullivan KL.

Mov Disord. 2007 Aug 15;22(11):1660-3.

PMID:
17580330
15.

Topiramate in essential tremor: a double-blind, placebo-controlled trial.

Ondo WG, Jankovic J, Connor GS, Pahwa R, Elble R, Stacy MA, Koller WC, Schwarzman L, Wu SC, Hulihan JF; Topiramate Essential Tremor Study Investigators..

Neurology. 2006 Mar 14;66(5):672-7.

PMID:
16436648
17.

Effect of amantadine in essential tremor: a randomized, placebo-controlled trial.

Gironell A, Kulisevsky J, Pascual-Sedano B, Flamarich D.

Mov Disord. 2006 Apr;21(4):441-5.

PMID:
16229019
18.
19.

Pharmacokinetics, safety, and tolerability of the new antiepileptic carisbamate in the elderly.

Levy R, Ragueneau-Majlessi I, Solanki B, Zannikos P, Yao C, Novak G.

Epilepsy Res. 2008 Mar;79(1):22-30. doi: 10.1016/j.eplepsyres.2007.12.013.

PMID:
18280116
20.

No benefit of 3,4-diaminopyridine in essential tremor: a placebo-controlled crossover study.

Lorenz D, Hagen K, Ufer M, Cascorbi I, Deuschl G, Volkmann J.

Neurology. 2006 Jun 13;66(11):1753-5.

PMID:
16769957
Items per page

Supplemental Content

Support Center